Tamarack Advisers LP lifted its stake in shares of NuVasive, Inc. (NASDAQ:NUVA) opened at $49.40 on Tuesday. Jana Partners Llc sold 919,040 shares as the company's stock declined 4.50% while stock markets rallied.
A number of large investors have recently added to or reduced their stakes in the business. Finally, AXA raised its stake in shares of NuVasive by 80.1% during the 4th quarter. Td Asset Management Inc bought 7,370 shares as the company's stock rose 9.64% with the market. Geode Capital Management LLC grew its holdings in NuVasive by 1.9% during the 4th quarter. Walleye Trading Ltd Liability Company owns 7,660 shares. Altrinsic Global Advisors LLC now owns 55,000 shares of the medical device company's stock worth $3,217,000 after purchasing an additional 5,000 shares during the period. Champlain Investment Partners LLC lifted its position in shares of NuVasive by 6.4% in the 4th quarter. Champlain Investment Partners LLC now owns 2,866,247 shares of the medical device company's stock worth $167,647,000 after purchasing an additional 171,455 shares during the period. C Worldwide Group Inc Hldgs A S holds 94,827 shares or 0.07% of its portfolio. NuVasive, Inc. The stock has a market capitalization of $2,560.00, a P/E ratio of 44.00, a P/E/G ratio of 1.30 and a beta of 0.50. ING Groep NV now owns 7,691 shares of the medical device company's stock worth $450,000 after purchasing an additional 1,469 shares in the last quarter.
US Won't 'Allow' Russian Meddling in Midterms
Trump picked up on that argument Tuesday, saying that the 2% of steel imported into the United States from China was misleading. Experts say the new sanctions are expected to target some subset of people from that list, though it's not yet clear who.
NuVasive, Inc. has a 12-month low of $44.62 and a 12-month high of $81.68. The company has a quick ratio of 1.94, a current ratio of 3.48 and a debt-to-equity ratio of 0.73. The medical device company reported $0.56 earnings per share for the quarter, meeting analysts' consensus estimates of $0.56. The firm had revenue of $271.70 million during the quarter, compared to analysts' expectations of $272.11 million. NuVasive had a net margin of 8.06% and a return on equity of 13.40%. The Highland Capital Management Lp holds 40,717 shares with $2.26 million value, up from 31,200 last quarter. During the same quarter a year ago, the firm posted $0.53 EPS.
A number of other equities analysts have also issued reports on NUVA. Royal Bank of Canada dropped their price target on shares of NuVasive from $75.00 to $70.00 and set an "outperform" rating on the stock in a research report on Friday, November 10th. Leerink Swann downgraded shares of NuVasive from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 1st.
LA Rams trade former Georgia LB Alec Ogletree; Todd Gurley not happy
The Los Angeles Rams continue to be extremely active on the trade front leading up to the start of free agency next week. They might really like Penn State running back Saquon Barkley and could trade down from that second overall selection.
Morgan Stanley reaffirmed their equal weight rating on shares of NuVasive (NASDAQ:NUVA) in a report released on Tuesday, February 27th. The rating was maintained by BMO Capital Markets on Tuesday, December 12 with "Buy". Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the stock. The stock has an average rating of "Buy" and a consensus price target of $68.19.
In other NuVasive news, CEO Gregory T. Lucier purchased 6,000 shares of the business's stock in a transaction on Thursday, March 1st. The stock was purchased at an average price of $48.57 per share, for a total transaction of $291,420.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The stock increased 2.55% or $1.26 during the last trading session, reaching $50.66. Caprock Gru Incorporated Inc has 0.07% invested in Deere & Company (NYSE:DE). NuVasive's highly differentiated, procedurally-integrated solutions include access instruments, implantable hardware and software systems for surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. (NASDAQ:NUVA). Oregon Public Employees Retirement Fund stated it has 18,677 shares.
Accusé de fraude fiscale, le couple renvoyé au tribunal correctionnel — Affaire Balkany
En octobre 2015, le couple avait déjà été mis en examen pour les mêmes raisons. Des biens non déclarés qui auraient dû être soumis à l'impôt sur la fortune.